SCHEMBL19983141

SCHEMBL19983141

[N-]=[N+]=Nc1cccc(C(N)=O)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 9/20 0.48
▸ POLB P06746 2/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ TSHR P16473 2/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ RECQL P46063 1/20 0.42
▸ BLM P54132 1/20 0.42
▸ PMP22 Q01453 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ PARP15 Q460N3 2/20 0.41
▸ PARP10 Q53GL7 2/20 0.41
▸ TNKS O95271 1/20 0.41
▸ PARP14 Q460N5 1/20 0.41
▸ TNKS2 Q9H2K2 1/20 0.41
▸ PARP2 Q9UGN5 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL29077427 0.98 PARP1 (0.47) PARP1POLBMEN1KMT2ATSHR
SCHEMBL13653935 0.84 MAOB (0.48) POLBMEN1KMT2AMAPTHSD17B10
Hydrochloric Acid SCHEMBL28856154 0.82 MAOB (0.47) POLBMEN1KMT2AMAPTHSD17B10
SCHEMBL14670993 0.82 ALDH1A1 (0.42) TSHRSIGMAR1
SCHEMBL13724974 0.82 ALDH1A1 (0.43) MEN1KMT2AMAPTCYP2C19TDP1
SCHEMBL27544567 0.79 SIGMAR1 (0.42) MEN1KMT2ACYP2C19TDP1SIGMAR1
SCHEMBL28617157 0.79 PARP1 (0.57) PARP1POLBMEN1KMT2ATSHR
SCHEMBL15714872 0.78 LOXL2 (0.47) POLBMEN1KMT2ATSHRMAPT
SCHEMBL19983030 0.78 HDAC8 (0.53) POLBMEN1KMT2AL3MBTL1
SCHEMBL1565391 0.77 PARP1 (0.55) PARP1POLBMEN1KMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4526291-A1 INDUCERS OF INTEGRATED STRESS RESPONSE TO TREAT CANCER The Board of Regents of the University of Texas System (US) 2025-03-26 — — EP disclosed
EP-4306166-A2 COMPOUNDS, COMPOSITIONS AND METHODS OF USE Aquinnah Pharmaceuticals Inc. (US) 2024-01-17 — — EP disclosed
CN-109983012-B Ketone inhibitors of lysine gum protease 莱特豪斯制药公司 2023-12-01 — — CN disclosed
CN-111698989-B Heterocyclic substituted pyridine derivatives as antifungal agents 安普利克斯制药公司 2023-08-01 — — CN disclosed
WO-2018053353-A1 KETONE INHIBITORS OF LYSINE GINGIPAIN Cortexyme, Inc. (US) 2018-03-22 — — WO disclosed
Send feedback